<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04506203</url>
  </required_header>
  <id_info>
    <org_study_id>HULaPaz</org_study_id>
    <nct_id>NCT04506203</nct_id>
  </id_info>
  <brief_title>The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool</brief_title>
  <official_title>The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool: a Multi-centre Prospective Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario La Princesa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Privado de Comunidad</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HYPOTHESIS:&#xD;
&#xD;
      During anesthetic pre-oxygenation with high FiO2, pulmonary atelectasis occur, especially in&#xD;
      patients &lt; 6 years old, where FRC and pulmonary closing volume may overlap. New borns and&#xD;
      children &lt;1 year old are especially vulnerable.&#xD;
&#xD;
      OBJECTIVES:&#xD;
&#xD;
        1. Validate &quot;air test&quot; as a individualized and non-invasive diagnostic method of clinically&#xD;
           significant atelectasis in pediatrics.&#xD;
&#xD;
        2. Determine what other factors contribute to atelectasis development in pediatrics&#xD;
&#xD;
      METHODS:&#xD;
&#xD;
      30 pediatric patients will be studied with ages ranged between 45 postconceptional weeks&#xD;
      and16 years old.&#xD;
&#xD;
      Baseline SpO2 and lung ultrasound will be performed for each patient upon arrival at the&#xD;
      operating theatre before preoxygenation with FiO2 of 1.0 SpO2 will be measured 15 min after&#xD;
      intubation during a 5 min long &quot;air test&quot; trial (FiO2 0.25). lung collapse will be verified&#xD;
      by lung ultrasound at the end of the 15 min trial. Lung collapse will be eventually granted&#xD;
      upon lung US verification by a blind researcher.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Lung Collapse will be diagnosed by a blind researcher that does not know the air test results</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Atelectasis incidence</measure>
    <time_frame>5 min</time_frame>
    <description>Assess incidence of SpO2 &lt; 97% 15 min after anesthesia induction during a 5 min long air test (FiO2 &lt; 0.25).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of Pediatric Air test trial</measure>
    <time_frame>5 min</time_frame>
    <description>Assess incidence of lung collapse (hence atelectasis incidence) 15 min after anesthesia induction using an air test (FiO2 &lt; 0.25). Collapse blind validation using lung US</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atelectasis risk factors assessment</measure>
    <time_frame>5 min</time_frame>
    <description>Determine if there occurs higher atelectasis incidence depending on age, sex, medical records, body weight index or type of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atelectasis severity</measure>
    <time_frame>5 min</time_frame>
    <description>Determine if there is any correlation between SpO2 values during air test and lung collapse, graded upon a validated severity lung collapse image score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Lung Collapse</condition>
  <condition>Lung Diseases</condition>
  <condition>Atelectasis</condition>
  <condition>Atelectasis Without Respiratory Distress Syndrome</condition>
  <condition>Atelectases, Resorption</condition>
  <condition>Air Test</condition>
  <condition>Pediatric Disorder</condition>
  <arm_group>
    <arm_group_label>Air test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Air test</intervention_name>
    <description>Patients will breathe 0.21 &lt; FiO2 &lt; 0.25 during 5 min and have a lung ultrasound perfomed at the end of the 5 min trial.</description>
    <arm_group_label>Air test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  General anesthesia&#xD;
&#xD;
          -  Perioperative risk classification (ASA) I, II, III&#xD;
&#xD;
          -  Newborns (postconceptional age&gt; 45 weeks) to 16 years&#xD;
&#xD;
          -  Need for oral / nasotracheal intubation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA &gt; III&#xD;
&#xD;
          -  Basal SpO2 &lt; 97% on air in supine position&#xD;
&#xD;
          -  Preoperative need for oxygen therapy and / or high-flow nasal cannulas&#xD;
&#xD;
          -  Expected Difficult airway&#xD;
&#xD;
          -  Presence of craniofacial disorders that may compromise ventilation&#xD;
&#xD;
          -  Hemodynamic instability and / or need for inotropics&#xD;
&#xD;
          -  History of untreated heart disease&#xD;
&#xD;
          -  Presence or history of pneumothorax&#xD;
&#xD;
          -  Presence of untreated congenital pulmonary disorders&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Weeks</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Privado de Comunidad</name>
      <address>
        <city>CÃ³rdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Princesa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>Patricio Gonzalez Pizarro</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>air test</keyword>
  <keyword>atelectasis</keyword>
  <keyword>pediatric</keyword>
  <keyword>non-invasive</keyword>
  <keyword>lung collapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Pulmonary Atelectasis</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD will be published in a peer reviewed journal</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Upon publishment in journal</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

